CURE8 Trademark Information

Trademark by Progenics Pharmaceuticals, Inc.

Providing temporary use of online, non-downloadable software for the storage of patient medical data and medical imaging data, the diagnosis and treatment of cancer, and medical data analysis; platform as a service (PAAS) featuring computer software platforms for the storage of patient medical data and medical imaging data, the diagnosis and treatment of cancer, and medical data analysis

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 8/1/2020
First Use In Commerce: 8/1/2020
General Information
Word mark: CURE8
Status/Status Date:
NEW APPLICATION FILED
2/13/2023
Serial Number: 97766262
Filing Date: 1/24/2023
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Providing temporary use of online, non-downloadable software for the storage of patient medical data and medical imaging data, the diagnosis and treatment of cancer, and medical data analysis; platform as a service (PAAS) featuring computer software platforms for the storage of patient medical data and medical imaging data, the diagnosis and treatment of cancer, and medical data analysis
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Progenics Pharmaceuticals, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
NEW APPLICATION FILED
2/13/2023
Correspondent Search:
DOUGLAS R. WOLF is a correspondent of CURE8 trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on